Ajanta Pharma board meeting scheduled for May 5, 2026 to approve audited financial results.
Meeting will consider both standalone and consolidated results for quarter and year ended March 31, 2026.
Disclosure made pursuant to Regulation 29 of SEBI Listing Regulations for mandatory corporate announcement.